Grants for small business in New Jersey — from the most pre-revenue-friendly state R&D credit in the eastern US to NJEDA business development programs and SBIR grants for one of the world’s largest pharmaceutical corridors.
New Jersey small businesses in 2026 have access to the most pre-revenue-friendly state R&D credit in the eastern US: the NJ R&D Tax Credit is fully refundable (100 cents on the dollar) with no statewide cap, meaning even a pre-revenue pharmaceutical startup receives cash from New Jersey for qualifying in-state research expenses. NJEDA programs (Emerge, Small Business Fund) support job-creating and growth-stage businesses. The NJ pharma corridor — spanning Morris, Somerset, Middlesex, and Mercer counties — is one of the world’s richest NIH SBIR geographies. New Jersey does not have a broad direct-grant program for general SMBs, but the federal R&D credit + fully refundable state R&D credit combination is uniquely powerful here, particularly for life sciences and biotech companies with qualifying New Jersey R&D wages.
New Jersey’s federal program strength is concentrated in its research university ecosystem (Princeton, Rutgers, NJIT) and its world-class pharmaceutical corridor. Check federal programs first: several have no geographic proration, no competitive cap, and can generate returns in year one regardless of state-level approvals.
The federal R&D credit equals 20% of qualified research expenses (QRE) above your historical base, or 14% via the Alternative Simplified Credit (ASC). For Qualified Small Businesses (under $5M gross receipts, under 5 years old), the credit offsets up to $500,000 per year directly against payroll taxes via Form 941, before any profitability. A Parsippany pharma startup with $900,000 in qualifying NJ research wages could extract $126,000 in federal payroll-tax credit per year — plus a fully refundable NJ state credit on the same wages.
The four-part federal test applies: research must be technological in nature, aimed at discovering information, conducted through a process of experimentation, for a qualified purpose. Pharmaceutical clinical trial costs generally do not qualify (the uncertainty is about the method of achieving a known outcome, not the discovery of the outcome itself — consult a tax advisor on which activities in your development pipeline qualify). Early-stage drug discovery, compound synthesis and testing for unknown targets, and novel formulation research have a stronger qualification case than Phase III clinical execution.
See full program details →| Feature | Federal Section 41 | New Jersey R&D Credit | Pennsylvania R&D Credit |
|---|---|---|---|
| Credit rate | 20% regular / 14% ASC | Set by NJ law on NJ QRE | 10% (20% for small biz under 25 PA employees) |
| Refundable? | No (QSB payroll-tax offset available) | Yes — fully refundable, 100 cents on dollar | No (but sellable at 85-90 cents) |
| Cap? | No statewide cap | No statewide cap | $55M annual statewide cap |
| History required? | No (ASC) | No minimum history | Yes — 2 years PA R&D history required |
| Application deadline? | Rolling (annual return) | Rolling (annual return) | December 1 hard cutoff annually |
New Jersey offers the cleanest pre-revenue R&D credit stack in the eastern US: federal QSB payroll-tax offset (immediate, quarterly, up to $500K/year) plus fully refundable NJ state credit (no cap, no sellability haircut, no deadline to miss). For a NJ pharma or tech spinout with $1M in qualifying NJ R&D wages, that’s potentially $140,000 in federal payroll-tax credit plus a meaningful NJ state refund — without profitability, without competing against other companies, and without a December 1 deadline to miss.
New Jersey’s pharmaceutical corridor is one of the most concentrated pharmaceutical R&D geographies in the world. Morris County (Parsippany, Florham Park, Morris Plains, Rockaway), Somerset County (Bridgewater, Basking Ridge, Bedminster), Middlesex County (New Brunswick, East Brunswick, Piscataway), and Mercer County (Princeton area, Lawrence Township) collectively host major pharma R&D operations from companies including Johnson & Johnson, Sanofi, Insmed, Daiichi Sankyo, Astellas, Otsuka, and many biotech spinouts from Rutgers University and Princeton University.
NIH SBIR Phase I is up to $323,090 for a 6-month feasibility study. Awards are peer-reviewed by study section according to scientific domain — match your target to the right NIH institute. NJ-relevant NIH institutes include:
Next standard NIH receipt date: September 5, 2026. Phase II follows at up to $2,153,927 for companies demonstrating Phase I feasibility. The NJ SBDC network and Rutgers Business School Entrepreneurship Program provide SBIR application coaching.
See full program details →NSF America’s Seed Fund backs deep-tech founders with up to $305,000 via a 3,500-character Project Pitch entry point. New Jersey’s research university ecosystem — Princeton University (computer science, physics, mathematics), Rutgers University (biology, materials science, chemistry, computer science), and NJIT (Newark, engineering, computing, design) — generates consistent NSF SBIR-eligible spinout companies. Princeton’s AI and machine learning research, Rutgers’ advanced materials and biotechnology programs, and NJIT’s engineering and nanotechnology research are the strongest NSF SBIR pipelines in New Jersey.
NSF SBIR does not fund biomedical companies focused on NIH-covered domains — the agencies have a deliberate division of covered territory. NSF funds computer science, engineering, materials science, environmental technology, manufacturing, and advanced robotics. Overall acceptance is about 12%.
See full program details →Section 45X provides per-unit production tax credits for US manufacturers of eligible clean energy components: solar modules ($0.07/watt), battery cells ($35/kWh), battery modules ($10/kWh), electrode active materials (10% of production costs), applicable critical minerals (10% of production costs), and inverters ($0.02–$0.065/watt). Wind components terminate after December 31, 2027.
New Jersey’s advanced manufacturing base in the Meadowlands (Bergen and Hudson counties), the Route 1 technology corridor in Middlesex County, and the southern NJ industrial zone in Camden and Burlington counties contains manufacturers producing electronics, specialty chemicals, and advanced materials that may qualify for 45X component credits. New Jersey is also a center of offshore wind development — the Atlantic Shores and Orsted projects off the NJ coast are creating a wind supply chain with potential 45X relevance for component manufacturers. Credits have no prevailing wage requirement, no application process, and are transferable.
See full program details →The Energy ITC equals 30% of qualifying clean energy property: solar, storage, geothermal, fuel cells, CHP, and biogas. New Jersey has specific energy community census tract designations in parts of southern New Jersey — particularly Atlantic City, Camden, Trenton, and sections of Salem and Cumberland counties with documented fossil-fuel employment history — where the energy community bonus adder (+10%) may apply, bringing effective ITC to 40%.
New Jersey also has an unusually active state-level solar incentive through the NJ BPU (New Jersey Board of Public Utilities) Successor Solar Incentive (SuSI) program and Transition Renewable Energy Certificates (TRECs) — these layer on top of the federal ITC and make NJ solar economics among the most favorable in the Mid-Atlantic. A NJ business installing rooftop solar can combine the 30% federal ITC with NJ’s state incentive programs for a significantly shortened payback period.
See full program details →New Jersey’s R&D Tax Credit is calculated on qualified research expenses (QRE) conducted within New Jersey. The key structural features that distinguish it from competing states:
Applications are filed with the New Jersey Division of Taxation as part of the annual NJ Corporation Business Tax return (CBT). The specific credit rate is set under NJ law — consult the NJ Division of Taxation website (state.nj.us/treasury/taxation/) or a New Jersey CPA for the current rate applicable to your tax year.
NJ Division of Taxation — R&D Tax Credit → Source: New Jersey Division of TaxationEmerge is the NJEDA’s primary economic development incentive program for businesses creating or retaining full-time jobs in New Jersey. It provides per-job tax credits against the NJ Corporate Business Tax, with credit amounts varying by:
Emerge requires businesses to create at least 35 net new full-time New Jersey jobs (lower thresholds — as few as 10 jobs — apply in targeted growth sectors like life sciences or in qualified incentive tracts in distressed southern NJ areas). The incentive is applied against NJ Corporate Business Tax over a credit period of up to 7 years. Applications must be submitted to and approved by NJEDA before the qualifying investments are made.
For NJ pharma corridor companies planning expansion, Emerge is worth evaluating if you are creating 35+ New Jersey jobs. The life sciences sector designation provides enhanced per-job credit amounts that can be material for pharma R&D companies adding research scientists in Middlesex or Morris counties.
NJEDA Emerge Program →NJEDA operates several programs for smaller New Jersey businesses beyond the Emerge incentive:
The New Jersey Board of Public Utilities (NJ BPU) administers several clean energy incentive programs for NJ businesses that layer on top of the federal ITC:
| Program | Amount | Best For |
|---|---|---|
| SBA 7(a) Loan | Up to $5M | Working capital, equipment, real estate — broad NJ lender network including Columbia Bank, Investors Bank, OceanFirst, M&T |
| SBA Microloan | Up to $50,000 | Newark, Camden, Trenton, and South Jersey startups — through CDFIs including the New Jersey Community Capital |
| NJ SBDC Network | Free advisory | NJ SBDC centers at Rutgers (statewide lead), NJIT (Newark), Kean (Union), Rowan (South Jersey), Stockton (Atlantic City) |
| SBA Women’s Business Centers | Free advisory | Women entrepreneurs statewide; New Jersey has multiple WBC locations in North and Central NJ |
| SBA Veterans BOC | Free advisory | Veteran founders statewide; NJ has significant veteran population from Fort Dix/Fort Meade corridor |
New Jersey’s pharmaceutical corridor — often called “Medicine Alley” — runs along the Route 202/206 corridor in Morris and Somerset counties (Parsippany, Florham Park, Basking Ridge, Bridgewater, Bedminster), continues into Middlesex County along Route 1 (New Brunswick, East Brunswick, Piscataway), and extends into Mercer County near Princeton. This geography has a higher density of pharmaceutical R&D employment than any comparably sized region in the world outside of Switzerland and Boston.
Your non-dilutive grant starting point is NIH SBIR Phase I (up to $323,090). Match your science to the correct NIH institute. Plan 4–6 months for application development. The NJ SBDC at Rutgers University provides SBIR coaching; Princeton’s entrepreneurship ecosystem supports biotech spinouts from the Princeton Neuroscience Institute, the Andlinger Center, and the departments of Chemistry and Molecular Biology.
Stack the federal Section 41 R&D credit on top of SBIR work. If you are a Qualified Small Business (under $5M gross receipts, under 5 years old), claim the QSB payroll-tax offset (up to $500,000/year against Form 941) from the moment you start paying qualifying NJ research wages — before revenue, before SBIR funding arrives. Add the fully refundable NJ R&D credit on the same NJ QRE base: no cap, no history requirement, cash refund even at zero NJ tax liability. This is the most complete non-dilutive R&D funding stack available to NJ pharma spinouts.
For companies growing to 35+ NJ employees: evaluate NJEDA Emerge for per-job incentives. Life sciences is a designated enhanced-credit sector under Emerge. Morris and Somerset county locations within qualified incentive tracts may receive higher per-job amounts. NJEDA business development staff can advise on whether your company’s growth plan meets Emerge thresholds.
Rutgers University also operates the Rutgers Office of Research Commercialization and several biotech incubators — including Johnson & Johnson Innovation at JLABS in Jersey City — that provide laboratory infrastructure and mentorship for early-stage NJ life sciences companies.
Northern New Jersey — particularly Bergen County (Hackensack, Paramus, Fort Lee), Essex County (Newark, Montclair, Livingston), Union County (Summit, Westfield), Hudson County (Jersey City, Hoboken) — has a large tech economy driven by proximity to New York City. The financial technology (fintech) sector is particularly strong in Jersey City and Hudson County, driven by the dense concentration of financial services companies that relocated or maintain operations there. Newark has an emerging innovation district anchored by NJIT and Rutgers Newark.
For NJ tech startups with qualifying R&D activity: the federal Section 41 QSB payroll-tax offset (up to $500K/year) combined with the fully refundable NJ R&D credit is your starting point. No competitive application. No deadline to miss. File federal Form 6765 and the NJ R&D credit on your annual return. For software development, the federal four-part test applies: qualifying activities must be aimed at discovering technological information (not simply adapting existing technologies), tested through a process of experimentation, and aimed at a qualified purpose. Internal-use software development for administrative functions generally does not qualify; externally-sold or embedded software development typically does.
NSF SBIR (up to $305,000) is the primary grant for NJ tech startups with defensible technological innovation: NJIT spinouts in computer science and engineering, Princeton computer science and AI research spinouts, and Rutgers computing and data science spinouts are the strongest NSF SBIR candidates in NJ. Jersey City and Newark’s emerging tech communities also generate candidates for NSF’s Innovation Corps (I-Corps) commercialization training, which can feed into SBIR Phase I applications.
NJEDA’s technology business development programs and the Newark Innovation Center (NIC) provide Newark-based tech companies with co-working, mentorship, and connections to NJEDA programs. The New Jersey Tech Council (NJTC) operates statewide networking and advocacy programs that connect NJ tech companies to NJEDA resources and funding roundtables.
New Jersey has a significant advanced manufacturing sector concentrated in the Meadowlands area (Bergen and Hudson counties), the Route 1 corridor (Middlesex and Mercer counties), and the southern NJ industrial zone (Camden, Burlington, Gloucester, Salem counties). Sectors include specialty chemicals, electronic components, medical devices, food processing, plastics, and precision metal fabrication.
For manufacturers installing on-site clean energy (solar arrays, CHP, energy storage): Section 48E ITC (30%) applies with no application process. South Jersey manufacturers in Salem, Cumberland, or Camden county industrial zones should check whether their specific census tract qualifies for the energy community bonus adder (+10%), bringing effective ITC to 40%. Combined with NJ BPU’s SuSI solar incentive, NJ solar economics for manufacturers are strong.
For manufacturers producing eligible clean energy components (solar modules, battery cells, critical minerals, inverters): Section 45X per-unit production credit has no application process, no cap, and is transferable. NJ specialty chemical and advanced materials manufacturers should evaluate whether their products fall within the 45X-eligible component categories before assuming they don’t qualify.
The NJ R&D credit applies to qualifying manufacturing process R&D conducted in NJ — if your production facility employs engineers or scientists developing new manufacturing processes, materials, or product formulations, those wages may qualify for both the federal Section 41 credit and the fully refundable NJ state credit. NJ manufacturers who have never claimed R&D credits because they don’t consider themselves “tech companies” frequently have unclaimed QRE in their engineering and quality departments.
The New Jersey Manufacturing Extension Program (NJMEP) provides NJ manufacturers with process improvement technical assistance, lean manufacturing training, and connections to NJEDA programs and federal NIST MEP resources. NJMEP services are partially subsidized for eligible NJ manufacturers.
South Jersey — Camden County, Atlantic County, Cape May County, Cumberland County, Salem County, Gloucester County — has a distinct economic profile from North Jersey’s financial services and pharma economy. Atlantic City’s hospitality and gaming economy, the Camden waterfront redevelopment zone, Vineland and Bridgeton’s agricultural and food processing economy, and Salem County’s industrial manufacturing base create different funding opportunities.
Atlantic City, Trenton, and Camden have significant Qualified Opportunity Zone designations, making QOZ-structured investment attractive for businesses in these cities through 2033. The Emerge program provides enhanced incentives for businesses creating jobs in designated NJ Opportunity Zone census tracts and qualified incentive tracts in South Jersey, where the per-job credit amounts are higher than northern NJ locations.
South Jersey food and agricultural businesses — the New Jersey Department of Agriculture (NJDA) administers programs for agribusinesses including the Farmlink NJ program, agricultural marketing programs, and connections to USDA Value-Added Producer Grants for NJ food businesses. Cumberland and Salem counties have significant vegetable farming, and Vineland has food processing operations that may qualify for USDA business and agricultural programs.
Camden County and Atlantic County businesses can access the NJ SBDC at Rowan University and Stockton University respectively for free business advisory services. NJ Community Capital provides CDFI lending in South Jersey for businesses that cannot access conventional bank credit, including CDFI-backed SBA Microloan funds.
Offshore wind is a particular opportunity for Atlantic County and Cape May County businesses. New Jersey is among the most ambitious offshore wind states in the US, with multiple projects off the Jersey Shore coast (Atlantic Shores Offshore Wind, Orsted/Eversource projects). Atlantic County-based businesses with marine, construction, logistics, or marine engineering capabilities should explore supply chain opportunities and potential Section 45X credits for offshore wind component manufacturing.
New Jersey has a diverse small business ecosystem and several targeted programs for underrepresented founders.
NJEDA administers the Main Street Recovery Finance Program (check njeda.gov for current availability — program rounds open and close periodically) for NJ small businesses, with specific allocations for businesses in underserved communities. The Edison Innovation Inclusive Innovation Fund targeted underrepresented NJ tech entrepreneurs; check NJEDA for current program availability.
At the federal level: SBA Women’s Business Centers operate across New Jersey. SBA Veterans Business Outreach Centers serve NJ veteran founders with free advisory services. SBA’s 8(a) Business Development Program (for socially and economically disadvantaged businesses) provides federal contracting preferences — valuable for minority-owned NJ businesses seeking federal contracting, particularly in North Jersey’s government-adjacent technology market and at Fort Dix/Joint Base McGuire-Dix-Lakehurst.
NJEDA operates the Diverse Community Capital program through NJ-based CDFIs specifically serving minority-owned businesses in NJ’s urban communities. New Jersey also has a robust WBENC (Women’s Business Enterprise National Council) certification presence through the Women’s Business Enterprise Council-East, which provides women-owned NJ businesses with corporate supplier diversity connections.
Private grants open to NJ founders include: the Amber Grant ($10,000 monthly for women entrepreneurs), NASE Growth Grants, and the Hello Alice Small Business Grant program. The Work Opportunity Tax Credit (WOTC) — $2,400 to $9,600 per qualifying new hire from target groups — is relevant for all NJ businesses expanding headcount from target populations; process WOTC pre-screening through the NJ Department of Labor. Note: WOTC expired December 31, 2025, and is pending Congressional reauthorization — continue pre-screening to preserve retroactive eligibility.
New Jersey’s geography is compact but economically diverse, ranging from the dense suburban economy of North Jersey to the pharma corridor of Central Jersey and the distinct ecosystems of Atlantic City, Trenton, and South Jersey.
North Jersey has the most urbanized and financially diverse economy in the state. Jersey City (Hudson County) has a major fintech and financial services cluster; Newark (Essex County) has NJIT, Rutgers Newark, and an emerging innovation district; Bergen County has a large concentration of healthcare and pharmaceutical operations. NJ SBDC at Rutgers and at NJIT (Newark) serve this region. NJEDA Emerge is most relevant for companies creating 35+ jobs in this high-cost region; per-job credits are lower here than in Opportunity Zone locations.
The heart of Medicine Alley and the geographic center of NJ’s pharmaceutical economy. NIH SBIR is the dominant grant program. NJ R&D credit (fully refundable, no cap) is particularly valuable here given the density of pharma R&D wages. Rutgers University (Piscataway and New Brunswick) is the anchor research university. Princeton (Mercer County) anchors the southern end of the corridor. NJEDA Emerge provides enhanced credits for life sciences companies in the corridor creating qualifying jobs.
Trenton is New Jersey’s capital city and has significant Opportunity Zone designations. Emerge provides enhanced per-job credits for Trenton-located businesses. NJEDA has targeted Trenton for economic development focus. NJ SBDC at MCCC (Mercer County Community College) serves Trenton-area SMBs. NJ Community Capital operates CDFI lending in Mercer County for businesses that cannot access conventional credit.
Atlantic City has extensive Opportunity Zone coverage and significant NJEDA interest in casino-adjacent economic diversification. Offshore wind development off the Atlantic County coast creates supply chain opportunities. NJ SBDC at Stockton University (Galloway, Atlantic County) serves this region. Atlantic City gaming and hospitality businesses have periodic access to NJ Reinvestment Development Authority (NJRDA) programs. USDA Rural Development programs apply to rural Atlantic and Cape May county businesses.
South Jersey has a mix of suburban Philadelphia-spillover economy in Camden and Burlington counties, agricultural processing in Salem and Cumberland, and the Camden waterfront redevelopment zone. NJEDA Emerge provides enhanced credits in Opportunity Zone and distressed community locations across South Jersey. Energy community bonus adders under IRA may apply to parts of Salem County (Salem nuclear plant closure adjacency) and former industrial zones in Camden. NJMEP serves South Jersey manufacturers. NJ SBDC at Rowan University covers Gloucester County.
Monmouth and Ocean counties have a mix of affluent suburban economy, a growing Asbury Park tech and creative economy, and significant retail and hospitality along the Jersey Shore. SBDC services are available through the Brookdale Community College SBC and the Chamber Foundation. Ocean County has some of the most active solar installations in NJ due to favorable conditions and NJ BPU SuSI incentives. Offshore wind projects visible from Ocean County beaches create potential supply chain awareness but the manufacturing opportunities are centered in Atlantic County ports.
1. Does your business conduct qualifying research (technology development, product R&D, process innovation, drug discovery, materials science)?
Yes, and you are a Qualified Small Business (under $5M gross receipts, under 5 years old):
Yes, and you are beyond QSB thresholds but R&D-active:
2. Are you a pharma or biotech company doing novel drug discovery or biomedical R&D?
Yes:
3. Are you a Princeton, Rutgers, or NJIT spinout in computer science, engineering, or materials science?
Yes:
4. Are you a manufacturer installing clean energy or producing eligible components?
Installing solar, CHP, storage, or geothermal on-site:
Producing solar modules, battery cells, critical minerals, or eligible inverters:
5. Are you planning to create 35+ New Jersey jobs in a qualifying sector?
Yes (life sciences, advanced manufacturing, clean energy, tech, finance/insurance):
6. Are you a micro-business, early-stage company, or business in South Jersey without R&D activity?
Yes:
New Jersey’s standout advantage for R&D-active companies is the fully refundable state R&D credit with no cap — stack this immediately with the federal Section 41 QSB payroll-tax offset for a cash return from the first qualifying wage you pay. For pharma corridor companies, add NIH SBIR Phase I as the non-dilutive grant layer. For Princeton and NJIT/Rutgers spinouts in deep-tech: NSF SBIR. For growing companies creating 35+ NJ jobs: NJEDA Emerge provides per-job incentives that can be material over the credit period. New Jersey’s R&D credit structure — refundable, no cap, no history requirement, no deadline — is the cleanest state R&D incentive in the eastern US for pre-revenue companies with qualifying research activity.
Answer a few questions about your business — industry, stage, location, and R&D activity — and see which New Jersey and federal programs match your profile, ranked by likelihood and effort.
Check My Eligibility — FreePremium insights at $29/mo — approval odds, insider eligibility tips, application timelines
What small business grants are available in New Jersey in 2026?
NJ small businesses in 2026 have access to the fully refundable NJ R&D Tax Credit (no cap), NJEDA Emerge for job-creating businesses in growth sectors, NJEDA Small Business Fund programs, NIH SBIR Phase I (up to $323,090) for pharma corridor companies, NSF SBIR (up to $305,000) for Princeton/Rutgers/NJIT spinouts, IRA Section 45X manufacturing credits, Section 48E ITC (30%), and NJ BPU clean energy incentives. New Jersey does not have a broad direct-grant program for general SMBs; the federal R&D credit plus refundable NJ state credit is the most broadly accessible starting point for R&D-active businesses.
Why is New Jersey’s R&D credit the best in the eastern US for pre-revenue companies?
New Jersey’s R&D credit is fully refundable (100 cents on the dollar, not 85-90 cents like Pennsylvania’s sellable credit) with no statewide cap (unlike Pennsylvania’s $55M competitive cap that gets prorated when oversubscribed) and no minimum history requirement (unlike Pennsylvania’s 2-year minimum). Pre-revenue NJ companies receive the NJ credit as cash even when they have zero NJ tax liability. Combined with the federal QSB payroll-tax offset (up to $500K/year on Form 941), a NJ startup can generate meaningful quarterly and annual cash returns from qualifying R&D activity without any competitive application or state-level deadline to miss.
What SBIR grants are available for NJ pharmaceutical and biotech companies?
NIH SBIR Phase I is the primary grant for NJ pharma corridor companies. Up to $323,090 for a 6-month feasibility study, peer-reviewed by NIH study sections by scientific domain. NJ pharma companies should match to the correct NIH institute: NCI (oncology), NIAID (infectious disease, vaccines), NHLBI (cardiovascular), NCATS (rare disease), NIBIB (devices and imaging). Next standard receipt date: September 5, 2026. Phase II follows at up to $2,153,927. NJ SBDC at Rutgers and NJIT provide free SBIR coaching. Princeton Entrepreneurship Council and J&J Innovation’s JLABS in Jersey City also provide pharma spinout SBIR support.
What is the NJEDA Emerge program and who qualifies?
NJEDA Emerge provides per-job tax credits for businesses creating or retaining full-time NJ jobs, with enhanced credits for life sciences, advanced manufacturing, clean energy, tech, and finance/insurance sectors. Businesses generally need to create at least 35 net new NJ full-time jobs (10-job threshold applies in targeted growth sectors and Opportunity Zone/distressed locations in South Jersey). Applications must be submitted to NJEDA before making qualifying investments. Contact NJEDA (njeda.gov) for a pre-application consultation; life sciences and advanced manufacturing companies in the pharma corridor or in Opportunity Zone locations receive the highest per-job credit amounts under Emerge.
Can I claim both the federal R&D credit and New Jersey’s R&D credit?
Yes — the two credits are stackable against the same qualifying research expenses. Both use the federal four-part test as the standard for qualifying research. File federal Form 6765 for the Section 41 credit and include the NJ R&D credit on your NJ CBT return. There is a federal interaction (IRC 280C) to consider: under the standard election, you cannot also deduct the qualifying expenses if you claim the full regular credit rate; under the reduced-rate election (280C(c)), you can deduct and still claim both federal and NJ credits. Consult a NJ-based CPA for optimal federal election strategy given the NJ credit stacking plan.
Are there NJ grants for women-owned, veteran-owned, or minority-owned businesses?
New Jersey does not have a large exclusive state grant program for these categories. NJEDA has run the Diverse Community Capital program through CDFIs for minority-owned NJ businesses. Federal programs are the primary path: SBA Women’s Business Centers across NJ, SBA Veterans BOC statewide, SBA 8(a) for socially disadvantaged businesses (provides federal contracting preferences). Private grants open to NJ applicants: Amber Grant ($10,000 monthly for women entrepreneurs), WBENC certification through WBEC-East for women-owned supplier diversity. WOTC ($2,400–$9,600/qualifying hire) benefits NJ businesses expanding headcount from target groups. Check NJEDA (njeda.gov) for currently open targeted rounds as programs open and close throughout the year.
Program details verified May 2026. NJ R&D credit rates, NJEDA Emerge program terms, and BPU incentive structures may change. Always confirm current parameters directly with NJEDA (njeda.gov), the NJ Division of Taxation, the IRS, or the relevant federal agency before filing. GrantCompass is an independent research platform and is not affiliated with any government agency.